TrianglePUBLICATIONS · 28854066
Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2017 Oct 20
- First author
- Demetri GD
This record carries publication-notice metadata. Review the notices below before relying on it.
Publication notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2018 Feb 1;36(4):432. doi: 10.1200/JCO.2017.77.4950.
- note
- Source null
- related pmid
- 29378157
- relationship
- Erratum in
Authors and identifiers
- name
- Demetri GD
- type
- Author
- name
- Schöffski P
- type
- Author
- name
- Grignani G
- type
- Author
- name
- Blay JY
- type
- Author
- name
- Maki RG
- type
- Author
- name
- Van Tine BA
- type
- Author
- name
- Alcindor T
- type
- Author
- name
- Jones RL
- type
- Author
- name
- D'Adamo DR
- type
- Author
- name
- Guo M
- type
- Author
- name
- Chawla S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Demetri GD
- type
- Author
- name
- Schöffski P
- type
- Author
- name
- Grignani G
- type
- Author
- name
- Blay JY
- type
- Author
- name
- Maki RG
- type
- Author
- name
- Van Tine BA
- type
- Author
- name
- Alcindor T
- type
- Author
- name
- Jones RL
- type
- Author
- name
- D'Adamo DR
- type
- Author
- name
- Guo M
- type
- Author
- name
- Chawla S
- type
- Author
- bibliography ids
- nci-bib-93373b1458c0adc818226a74
- book metadata
- content sha256
- 18fc1acb952c091a6e94a25f0fb9866e38567dff2b828c3425b8e6214c55463d
- document type
- citation
- dois
- 10.1200/JCO.2016.71.6605
- electronic publication date
- display
- 2017 Aug 30
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28854066
- immutable id
- pubmed:28854066@18fc1acb952c091a6e94a25f0fb9866e38567dff2b828c3425b8e6214c55463d
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 30
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3433-3439
- volume
- 35
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2018 Feb 1;36(4):432. doi: 10.1200/JCO.2017.77.4950.
- note
- Source null
- related pmid
- 29378157
- relationship
- Erratum in
- outcomes validated
- false
- pmid
- 28854066
- provenance
- batch id
- fb25b16edcb1373b70c1
- provider
- NCBI PubMed ESummary
- record sha256
- 5761331130b3d3fe67e74637d2b6a4ca0f0ff1ed521ab890269f1df09b1ab244
- response sha256
- 182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
- retrieved at
- 2026-09-09T23:47:28.490065+00:00
- publication date
- display
- 2017 Oct 20
- precision
- day
- year
- 2017
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine.
Preserved source evidence · Not medical advice